The Centers for Medicare & Medicaid Services (CMS) released the 2023 Medicare Advantage and Part D proposed rule. The proposal aims to advance the administration’s efforts to improve consumer protections, reduce disparities, and improve health equity in Medicare Advantage (MA) and Part D.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
The U.S. Department of Health and Human Services (HHS) has announced the availability of nearly $48 million in grants for community-based organizations to expand public health capacity in rural and tribal communities through health care job development, training, and placement.
A large study of EHRs published on January 5, 2022, in JCO Clinical Cancer Informatics uses CancerLinQ data to further highlight the need to minimize the administrative burden of quality reporting and to strengthen the use of data standards to improve the real-world quality of care for patients with cancer.
On December 29, 2021, CMS issued a final rule rescinding the Most Favored Nation (MFN) model. MFN was originally proposed in November 2020 and scheduled to be implemented on January 1, 2021. The Association for Clinical Oncology (ASCO) and other groups strenuously opposed what would have been a mandatory model that would have decimated cancer care in the U.S. by significantly decreasing Medicare beneficiary access to treatment.